Amir Weiss is CAO at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). They have made 7 open-market trades across 1 company since 2023, most recently 2026-08-21.
CIK 0001897057
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TEVA | 13,071 | $542K |
Shares reported on the most recent Form 4, priced at the 2026-08-25 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TEVA | SELL | 2026-08-21 | 2026-08-25 | $37.62 | $355K | -3.5% | +6.7% | — |
| TEVA | SELL | 2026-05-06 | 2026-05-07 | $36.00 | $384K | -5.9% | -8.2% | -4.2% |
| TEVA | SELL | 2025-12-16 | 2025-12-18 | $30.20 | $371K | +3.7% | +4.2% | -1.6% |
| TEVA | SELL | 2025-11-06 | 2025-11-10 | $24.44 | $301K | -0.4% | +22.2% | +41.4% |
| TEVA | SELL | 2024-05-15 | 2024-05-17 | $16.71 | $681K | +2.7% | +4.1% | +11.4% |
| TEVA | SELL | 2024-02-01 | 2024-02-05 | $12.37 | $786K | +6.3% | +8.9% | +13.2% |
| TEVA | SELL | 2023-08-04 | 2023-08-07 | $9.92 | $20K | -0.1% | -0.4% | -4.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.